Phytonadione for parenteral administration
AssigneeFresenius Kabi Austria GmbH
InventorsPatricia SEGER, Theofanis MANTOURLIAS, Lorena MUGGETTI
Life of this patent
Estimating the term…
Abstract
The present invention relates to an aqueous pharmaceutical composition for parenteral administration to a human, comprising a pharmacologically effective amount of a pharmaceutically acceptable vitamin K, a polyethoxylated castor oil as solubilizer, and a citrate buffer at a concentration of 1 to 40 mmol/L, wherein the pH of the composition is between 3.5 and 7.0, to a pharmaceutically acceptable container comprising the composition, and to the composition for use in the treatment or prevention of vitamin K deficiency and/or haemorrhage or for use as an antidote to anticoagulants of the coumarin type as well as to a method for preparing the composition.
Claims21
1-16. (canceled)
An aqueous pharmaceutical composition for parenteral administration to a human, comprising a pharmacologically effective amount of a pharmaceutically acceptable vitamin K, a polyethoxylated castor oil as solubilizer, and a citrate buffer at a concentration of 1 to 40 mmol/L, wherein the pH of the composition is between 3.5 and 7.0.
Dependencies are inferred from the claim text.